loader
Please Wait
Applying Filters...
menu
    • menu

    Technical details about Deutivacaftor, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Deutivacaftor

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: D9-ivacaftor, Ivacaftor d9, Ivacaftor-d9, Sha6u5fjzl, 1413431-07-8, Deutivacaftor [usan]
    Molecular Formula
    C24H28N2O3
    Molecular Weight
    401.5  g/mol
    InChI Key
    PURKAOJPTOLRMP-ASMGOKTBSA-N
    FDA UNII
    SHA6U5FJZL
    Deutivacaftor is under investigation in clinical trial NCT03227471 (A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis).
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    N-[2-tert-butyl-4-[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]-5-hydroxyphenyl]-4-oxo-1H-quinoline-3-carboxamide
    2.1.2 InChI
    InChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)/i4D3,5D3,6D3
    2.1.3 InChI Key
    PURKAOJPTOLRMP-ASMGOKTBSA-N
    2.1.4 Canonical SMILES
    CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C
    2.1.5 Isomeric SMILES
    [2H]C([2H])([2H])C(C1=C(C=C(C(=C1)C(C)(C)C)NC(=O)C2=CNC3=CC=CC=C3C2=O)O)(C([2H])([2H])[2H])C([2H])([2H])[2H]
    2.2 Other Identifiers
    2.2.1 UNII
    SHA6U5FJZL
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. D9-ivacaftor

    2. Ivacaftor D9

    3. Ivacaftor-d9

    4. Sha6u5fjzl

    5. 1413431-07-8

    6. Deutivacaftor [usan]

    7. Ctp-656

    8. Vx-561

    9. N-[2-tert-butyl-4-[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]-5-hydroxyphenyl]-4-oxo-1h-quinoline-3-carboxamide

    10. Unii-sha6u5fjzl

    11. Deutivacaftor [inn]

    12. Deutivacaftor (usan/inn)

    13. Deutivacaftor [who-dd]

    14. Chembl4297603

    15. Schembl15504743

    16. Hy-13017s

    17. Who 10704

    18. Db15141

    19. Cs-0068247

    20. D11423

    21. 3-quinolinecarboxamide, N-(2-(1,1-dimethylethyl)-4-(1,1-di(methyl-d3)ethyl- 2,2,2-d3)-5-hydroxyphenyl)-1,4-dihydro-4-oxo-

    22. N-(2-tert-butyl-5-hydroxy-4-(2-(2h3)methyl(1,1,1,3,3,3-2h6)propan-2-yl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide

    2.4 Create Date
    2013-06-10
    3 Chemical and Physical Properties
    Molecular Weight 401.5 g/mol
    Molecular Formula C24H28N2O3
    XLogP35.6
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count4
    Rotatable Bond Count4
    Exact Mass401.26648347 g/mol
    Monoisotopic Mass401.26648347 g/mol
    Topological Polar Surface Area78.4 Ų
    Heavy Atom Count29
    Formal Charge0
    Complexity671
    Isotope Atom Count9
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1